Chevallard Daniel R. bought LENZ
March 27, 2026 · Form 4 insider transaction
Chevallard Daniel R. bought 7,500 shares of LENZ Therapeutics, Inc. at $8.57 per share, a transaction worth $64.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,500
Price
$8.57
Total value
$64.3K
InsiderChevallard Daniel R.
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 27, 2026
Filing dateMarch 30, 2026
Shares owned after12,886
OwnershipDirect
10b5-1 planNo
AmendedNo